問題 › 採用するかアウトソースするか › 会計・アドバイザリー事務所
判断基準は1時間あたりのコストではありません。能力がコンプライアンスやアドバイザリー業務に近く、所有することで実現率やアドバイザリー獲得率が上がるかどうかです。 会計事務所に当てはまる問い方は一般論とは異なります。コンプライアンス報酬の圧縮と、法定業務を減らさずに時間を移せない点です。82%実現率を無視した答えは誤りです。分析は71%の請求可能稼働率と34%のアドバイザリー獲得率から始めなければなりません。
判断基準は1時間あたりのコストではありません。能力がコンプライアンスやアドバイザリー業務に近く、所有することで実現率やアドバイザリー獲得率が上がるかどうかです。 会計事務所に当てはまる問い方は一般論とは異なります。コンプライアンス報酬の圧縮と、法定業務を減らさずに時間を移せない点です。82%実現率を無視した答えは誤りです。分析は71%の請求可能稼働率と34%のアドバイザリー獲得率から始めなければなりません。
採用かアウトソースかは通常、請求可能時間や稼働率で論じられますが、これは最も影響の小さい要素です。アウトソースは稼働率が低いほど安く、高いほど高くなります。比較は予測可能なコンプライアンス業務量に基づきます。
決定的な問いは、実際に販売するものとの近さです。コンプライアンス顧客の体験に触れたり、アドバイザリーに活用できる知識を蓄積したりする能力は、割高でも所有する価値があります。それ以外は調達判断です。
三つ目の要素は変動です。所有すれば品質とタイミングを制御でき、アウトソースすれば柔軟性が得られます。どちらが重要かは、コンプライアンス顧客が変動に気づき、継続に影響するかどうかによります。
この3つが揃うと特徴的です。1つだけでは別のことを示すことが多いです。
✓ 議論が実現率や請求可能時間だけで行われている
✓ 採用者の稼働率が、仕掛中の業務から見積もられていない
✓ その機能がコンプライアンス顧客に直接触れる
通常、事態を悪化させる対応です。 アドバイザリーに活用できる知識を蓄積するものをアウトソースし、毎年アドバイザリー獲得率を下げ、粗利益率を弱めることです。
It is for you if you run or finance an accounting firm and the debate is being conducted entirely on hourly rates. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 会計事務所. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Pennmark Advisory, a sample company profile used for testing rather than a customer — 43.2m total revenue with 210 fte staff.
Excerpt from a real Percision run · Pricing Strategy · sample company profile
The move. Convert 15,000 compliance hours into $1.9M incremental EBITDA by embedding advisory inside existing client relationships.
| Investment required | $0.8M-$1.2M for 6 FTE conversion specialists (salary + training); funded entirely from existing $7.8M EBITDA within 24-month payback constraint |
| Expected return | Base case: $1.9M incremental EBITDA on $1.0M investment = 1.9× return within 24 months; Low case: $1.4M EBITDA (26% lower pipeline conversion); High case: $2.4M EBITDA (26% higher win rate) |
| Revenue, year 1 | $0.6M incremental advisory revenue (partial year, 6 specialists hired Q2 2027) |
| Revenue, year 2 | $1.9M incremental EBITDA (full-year run rate) |
| Revenue, year 3 | $2.8M incremental EBITDA (additional 4 specialists funded by Year 2 cash flow) |
| Exit criteria | Strategy should be reversed if, within 18 months, (a) advisory win rate falls below 25% for two consecutive quarters, OR (b) compliance retention drops below 88%, OR (c) incremental EBITDA from conversion specialists fails to reach $800K annual run-rate by Month 18 |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to 組織アライメントモデル, one of 29 engagements the platform runs. For 会計事務所 it works through 82% realisation rate, 71% billable utilisation, 34% advisory win rate and 91% compliance client retention, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 完全なレポートはこちらをご覧ください if you would rather see the depth first.
内部の総コストが同等の外部単価を下回る稼働率になったときです。その損益分岐点を明示的に計算してください。通常想定より低く、そこまでで議論は終わります。
蓄積した知識が販売するものの一部になる場合です。それを失うことはコストではなく、請求できる金額が徐々に減ることを意味します。
平均ではなくばらつきで比較します。アウトソースは平均では同等でもばらつきが大きく、顧客が気づくかどうかがそのまま重要になります。
Materially, yes. Compliance fee compression and inability to shift hours to advisory without reducing statutory output — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82% realisation rate, 71% billable utilisation, 34% advisory win rate, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82% realisation rate and 71% billable utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית